FT : Fed drops pledge to be ‘patient’ on rate rises


Fed drops pledge to be ‘patient’ on rate rises

The Federal Reserve has dropped its pledge to be “patient” before raising interest rates, freeing its hand to lift official borrowing costs for the first time in nearly a decade.
The US central bank left its target range for short-term rates at zero to a quarter per cent today, adding that it did not expect to pull the trigger on rate rises as soon as April, but opening up its options from June onward.

However, it also reduced its forecasts for growth and inflation and projections of interest rates, suggesting the Fed may wait longer than June — the first date available for a hike.
In a statement, the Federal Open Market Committee said it anticipated lifting rates when it had seen further improvement in the labour market and was “reasonably confident” that inflation would move back to its 2 per cent target over the medium term. This new language did not mean the committee has made up its mind when to raise rates, however, the statement added.
The biggest market reaction was seen in US equities, where the broad S&P 500 index erased losses to rise 1.1 per cent. Investors bought up US Treasuries, pushing yields on the benchmark 10-year note 6 basis points lower and back below 2 per cent.
The dollar weakened, with the euro jumping as much as 1 per cent against the US dollar to trade at $1.068.
The decision came in the most hotly anticipated Fed meeting since Janet Yellen took the chair of the central bank more than a year ago. The dollar has been trading at multiyear highs against a range of currencies, partly in anticipation of higher borrowing costs in the US following over six years of near-zero rates, but also as some two dozen other central banks have eased policy this year.
These gains have sparked concerns that the US economic growth outlook could be dented as exports sag, and that the Fed’s inflation expectations could be shaved back. The International Monetary Fund’s Christine Lagarde warned that rate rises could trigger instability in emerging markets, while one prominent hedge fund manager, Ray Dalio, warned of the risk of a 1937-style stock market slump when it finally raises rates
In a press conference after the statement, Ms Yellen said the change in language did not mean the Fed had become “impatient” about raising rates.
The statement did not mention the dollar explicitly, but Fed rate-setters reduced their growth and inflation outlook, as well as their expectations for the pace at which rates will be hiked in the coming years, perhaps reflecting that dollar influence. They also reduced their estimates for unemployment as job growth continues to defy analyst expectations.
The FOMC also noted that export growth had “weakened”, in an implicit acknowledgment of the dollar’s influence.
Dan Greenhaus, chief strategist at BTIG said: “The FOMC is looking for ‘further’ improvement, meaning the economy and labour market has not yet met whatever criteria necessary to warrant a rate hike. We remain of the belief the Fed will first raise rates in September and view this statement, and the projection changes, as reducing the odds of a June hike.”
Ms Yellen on February 24 paved the way for the “patience” pledge to be ditched, as she sought to give the Federal Open Market Committee a freer hand to change rates when it saw fit. The promise committed the FOMC to holding rates unchanged for at least two meetings. This would have ruled out hikes in June if it had been reiterated today.

In new projections, FOMC members reduced their growth outlooks for 2015, 2016 and 2017, with the central tendency for 2015 reduced to 2.3-2.7 per cent from 2.6-3 per cent.
Countering that was a reduction in the unemployment rate, which is now seen at 5-5.2 per cent this year, down from 5.2-5.3 per cent, and to 4.9-5.1 per cent in 2016 from 5-5.2 per cent.
The FOMC’s estimate that the longer-run normal rate of unemployment is now 5-5.2 per cent, lower than previously estimated, and suggesting there may be more slack in the labour market than previously believed. That could give the FOMC scope for a shallower path of monetary tightening.
Its outlook for core inflation was reduced to 1.3-1.4 per cent this year, from 1.5-1.8 per cent previously, and to 1.5-1.9 per cent for 2016 from 1.7-2 per cent previously. However the view for 2017 was left unchanged at 1.8-2 per cent, suggesting the FOMC still sees the low inflation readings as transitory.
Alongside growth forecasts that shaved back the FOMC’s outlook, Fed rate-setters set out their projections for the central bank’s key rate until 2017.
These showed median expectations for the end of 2015, 2016 and 2017 being cut. The outlook for 2015 was reduced to 0.625 per cent from 1.125 per cent in December, and to 1.875 per cent for 2016, lower than the 2.5 per cent prior median. The outlook for 2017 was for rates of 3.125 per cent. That remains well above measures of market expectations, which suggest the federal funds rate will only hit 2 per cent in 2017. The projection for the longer-run rate remained at 3.75 per cent.

RELATED TOPICS
Federal Reserve USA
Copyright The Financial Times Limited 2015. You may share using our article tools.
Please don't cut articles from FT.com and redistribute by email or post to the web.
Gift ArticleShareClipReprintsPrintEmail
info
Content recommended for you

Based on your browsing history
US Fed: what to watch for from Janet Yellen
Free Lunch: Economy watchers and '30s throwbacks
Reminder: US Macro Live special edition, Fed presser edition
The bet on a stronger dollar is all-encompassing
Strong currents that keep interest rates down
Dalio warns Fed of 1937-style rate risk
Asset managers cut exposure to US stocks
Yellen keeps Fed options open on rates rise
The Federal Reserve is ready for ‘lift off’ on interest rates
Five questions ahead of US Federal Reserve meeting
COMMENTS (6)
Sign in

Submit Comment
By submitting this comment I confirm that I have read and agreed to the FT Terms and Conditions. Please also see our commenting guidelines.
Newest | Oldest | Most recommended
Jack Armstrong 1 minute ago
Pent-up demand from the bad weather across the US is going to light up retail soon, my opinion. And after the last, fantastic 300k jobs report, GDP is going to be revised upward.
Coming soon: a modest rate increase. The Fed will put its toes in the water and see what it feels like.

RecommendReply
XRayD 3 minutes ago
Bank robbers entered a bank shouting: "Don't move! The money belongs to the bank."
After the theft the younger robber said to the older: "Hey, maybe we should count how much we stole." The older man replied: "Don’t be stupid. It's a lot of money so let's wait for the news to be told how much money was taken from the bank."
Meanwhile, at the bank the manager said to the accountant: "Let's call the cops." The accountant replied: "Wait, before we do that let's add the $800,000 to the robbery of that we took to ourselves a few months ago and just say that it was stolen."
The following day it was reported in the news that the bank was robbed in of $ 3 million. The robbers counted the money, but they found only $1 million so they started to grumble. "We risked our lives for $1 million, while the bank's management robbed two million dollars without blinking? Maybe its better to learn how to work the system, instead of being a simple robber."
Moral :Give a person a gun, and he can rob a bank . Give a person a bank, and he can rob everyone.

Reckitt Benckiser (RB.L)

Growth injection – upgrading to OW
Supercharge compresses growth into the equity story and powers sales and EBIT, while the strategic optionality in Consumer Health could drive a step-change in RB's growth. With one of the best risk-rewards in Staples, we move OW.
What's Changed?

Risk-reward appeal, top pick in HPC: The launch of the Supercharge cost saving program and the strategic optionality we see give Reckitt Benckiser (RB) one of the most attractive risk-rewards in the sector, in our opinion. We are now more confident about Supercharge's delivery and raise our EPS estimates by ~3-4% from 2015, which takes 2015-17 CAGR to 8%+ and puts us ~5% ahead of consensus in 2015-16. In this report we examine hypothetical portfolio changes that RB could make, which we capture in our Bull case.

Supercharge – an engine of sales and EBIT growth to 2017. The market underestimates the potential for Supercharge to drive both top-line and EBIT growth from 2015, we argue. The program's focus on new sources of efficiency gains in SG&A gives us confidence that RB can deliver the targeted savings from 2015, driving superior EBIT margin progression. We expect the organisational streamlining that Supercharge entails to boost top-line growth (~5% ongoing) as RB better leverages scale with larger, more rapid innovation.

Strategic optionality – reshaping the portfolio towards Health. RB's shift towards Consumer Health has the potential to generate a step-change in its growth and margin profile, making it a standout growth story in Staples and returning it to the premium it used to enjoy when growing at the top end of its peer group (our Bull case of 7,400p). A scenario we examine here is if RB were to extend the process of portfolio reshaping to include the disposal of all or part of its Home division. In such a case, we think the total value could be £4.7-5.4 billion. If this were accompanied by acquisitions of £5bn in Consumer Health, it could take group structural growth from ~5% to 6-7%, with low teens EPS growth, our analysis suggests.

Attractive entry point, re-rating potential: With the HPC sector having seen a significant re-rating, RB's recent relative underperformance creates an attractive entry point ahead of strong earnings delivery in 2015 and 2016, we think. At ~23x 2015e PE, valuation is at the upper-end of its historical range but upside earnings surprises should drive upside.

>>>Asian Update

Asian Mid-session Update: China property prices slide again; USD listless ahead of key Fed decision


***Economic Data***
- (CN) CHINA FEB NEW HOME PRICES M/M: FALL IN 66 OUT OF 70 CITIES VS 64 PRIOR; Y/Y: FALL IN 69 CITIES V 69 PRIOR
- (JP) JAPAN FEB MERCHANDISE TRADE BALANCE: -¥425B (smallest deficit in 2 years) V -¥987BE; ADJ TRADE BALANCE: -¥639B V -¥1.2TE
- (AU) AUSTRALIA FEB WESTPAC LEADING INDEX M/M: 0.3% V 0.1% PRIOR
- (NZ) NEW ZEALAND Q4 CURRENT ACCOUNT BALANCE (NZ$): -3.2B V -3.1BE
- (KR) SOUTH KOREA FEB UNEMPLOYMENT RATE: 3.9% V 3.4%E
- (SL) SRI LANKA LEAVES REVERSE REPO RATE UNCHANGED AT 8.00% (EXPECTED); LEAVES REPURCHASE RATE UNCHANGED AT 6.50% (EXPECTED)

***Index Snapshot (as of 02:30 GMT)***
- Nikkei225 -0.1%, S&P/ASX -0.6%, Kospi +0.2%, Shanghai Composite +0.7%, Hang Seng +0.9%, Jun S&P500 flat at 2,066

***Commodities/Fixed Income***
- Apr gold +0.2% at $1,150, Apr crude oil +0.2% at $42.58/brl
- (NZ) Fonterra Global Dairy Trade auction: Dairy Trade price index -8.8% (first decline in 7 auctions) from prior auction v +1.1% prior
- (US) API PETROLEUM INVENTORIES: CRUDE: +10.5M (largest build in 4 weeks) v +4Me, GASOLINE: -0.58M v -1Me, DISTILLATE: -0.25M v -0.5Me
- GLD: SPDR Gold Trust ETF daily holdings fall 2.7 tonnes to 748.0 tonnes; Lowest since Jan 26th
- JGB: (JP) Japan's MoF sells ¥1.09T in 1.2% (1.2% prior) 20-year JGBs; Avg yield: 1.199% v 1.274% prior; bid-to-cover: 3.42x v 3.51x prior
- (AU) Australia MoF (AOFM) sells A$700M in 4.25% bonds due 2026; Avg yield: 2.5432%; Bid-to-cover: 3.86x
- USD/CNY: PBoC sets yuan mid point at 6.1556 v 6.1585 prior setting (strongest yuan setting since Mar 6th)

***Market Focal Points/FX***
- China indices are leading Asia trade yet again, with particular strength observed among the property developers on expectation of more govt intervention. China property price average in the top 70 cities fell for the 10th consecutive month sequentially, and y/y decline accelerated to -5.7% from -5.1%. Top-tier Beijing and Shanghai markets were not immune to the February slowdown, falling by 3.6% and 4.7% respectively. Stats Bureau has once again hid behind the holiday seasonality in explaining away the decline, forecasting a significant rebound in March.

- All eyes are on the FOMC policy statement in the US on Wednesday, with much of the focus falling on whether the statement will take out the "patient" language as forecasted by Fed watcher Hilsenrath. USD majors are particularly quiet before tomorrow's storm - EUR/USD is trading about 10pips on either side of $1.06 mark, USD/JPY is in a 15pip range below 121.40, and AUD/USD in a 20pip range below 0.7630. NZD fell nearly 100pips during the US session, accentuated by loss following the first decline in Fonterra auction price in 4 months, but remains supported above 0.73 in Asia. Also of note in New Zealand, Q4 current account registered a slightly wider than expected current account deficit ahead of tomorrow's GDP report.

- In Japan, a number of automakers largely confirmed press speculation related to their spring wage negotiations - Toyota raises monthly base pay by ¥4K, Nissan by ¥5K, and Mitsubishi Motors by ¥2K - well below its union's request of ¥6K/month. Sony revised its Q3 higher and traded up 5%, while Nintendo was in bid-only mode up 20% on partnership with DeNA in mobile gaming. Japan trade data finally showed some improvement, posting its smallest headline deficit in 2 years on much higher than expected exports and surprise decline in imports. Shipments to China fell 14%, but those to US were up 14% and Europe up 2%.

***Equities***
US markets:
- VRML: Unit entered into three agreements with Quest Diagnostics - filing; +35.8% afterhours
- ZQK: Reports Q1 -$0.11 v -$0.13 y/y, R$341M v $337Me; +16.5% afterhours
- WIX: Guides Q1 higher R$44-45M v $44Me (prior $43-44M); EBITDA -$1M to -$2M v -$4 to -$3M prior; +10.1% afterhours
- HLF: Los Angeles Federal Judge: Herbalife wins dismissal of shareholders' pyramid scheme suit; +3.7% afterhours
- ORCL: Reports Q3 $0.68 (adj) v $0.68e, R$9.33B v $9.45Be; Raises quarterly dividend 25% to $0.15/shr; +1.7% afterhours
- STLD: Guides Q1 $0.12-0.16 v $0.24e; -3.1% afterhours
- ADBE: Reports Q1 $0.44 v $0.39e, R$1.11B v $1.08Be; -3.8% afterhours
- NKTR: Etirinotecan Pegol (NKTR-102) Prolonged Median Overall Survival by 2.1 Months versus Active Control in Patients with Advanced Breast Cancer in Phase 3 Study; Trial Did Not Achieve Statistical Significance; -16.8% afterhours

Notable movers by sector:
- Consumer Discretionary: Zensho Holdings 7550.JP +1.8% (sells asset)
- Financials: China Aoyuan Property Group 3883.HK +2.3% (FY14 results); Ping An Insurance 601318.CN +1.5% (restructure of Lufax); China Vanke 000002.CN +2.0%, Poly Real Estate 600048.CN +3.9%, China Merchants Property 000024.CN +3.3% (China Feb home prices)
- Materials: Wuhan Iron & Steel 600005.CN +3.4%, Xinjiang Ba Yi Iron & Steel 600581.CN +10.1% (comments on M&A activities in steel industry); Fortescue FMG.AU -7.1% (scraps plan of notes offering, citing unmet cost objectives)
- Energy: Huaneng Renewable Corp 958.HK +3.8% (FY14 results)
- Industrials: Boral Ltd BLD.AU +1.0% (plans buyback)
- Technology: Nintendo 7974.JP +21% (to sell shares to DeNA; to design mobile games with DeNA); Sony 6758.JP +5.3% (revises Q3 results)

>>>US_Summary RXDX +26.3%, FRSH +18.4%, ORCL +1.7%, FPRX

After Hours Summary: RXDX +26.3%, FRSH +18.4%, ORCL +1.7%, FPRX -7.2%, ADBE -4% following earnings/guidance

After Hours Gainers:

Companies trading higher in after hours in reaction to earnings: RXDX +26.3%, FRSH +18.4%, ZQK +17.7%, WIX +9.3%, AEZS +7.4%, ENTL +4.2%, BONE +3.5%, CPXX +2.9%, ORCL +1.7%, NVGS +1.6%, MCUR +0.8%, WG +0.7%, EVOL +0.1%

Companies trading higher in after hours in reaction to news: VRML +30.1% (entered into three agreements with Quest Diagnostics (DGX): a global settlement agreement and mutual release, a testing and services agreement, and a non-exclusive license agreement), RXDX +26.3% (co and Teva Pharmaceuticals (TEVA) announced acquisition by Ignyta of four oncology R&D assets from Teva in exchange for 1.5 mln shares (6%) of Ignyta's common stock; RXDX also reported earnings), AKRX +5.5% (announced filing of 10-K for year ended December 31, 2014; in addition to second and third quarter 2014 financial statements), NETE +5.2% (co confirmed it will acquire PayOnline),  HLF +4.5% (seeing reports that co has received a favorable court ruling), CIM +1.6% (announced that the Board has approved a reverse stock split of Chimera's outstanding shares of common stock at a ratio of 1-for-5; increased quarterly dividend to $0.096/share from $0.09/share), 

After Hours Losers:

Companies trading lower in after hours in reaction to earnings: FPRX -7.2%, ADBE -4%, OXGN -2.9%, EKSO -1.5%

Companies trading lower in after hours in reaction to news: NKTR -15.0% (announced Phase 3 BEACON study evaluating single-agent NKTR-102 in patients with advanced breast cancer did not meet its primary and secondary endpoints), ANTH -8.0% (announced proposed public offering of common stock; size and price details not disclosed), RSPP -4.0% (announced the commencement of an underwritten public offering of 5 mln shares of its common stock by the Company and 4 mln shares of its common stock by certain selling stockholders), ESPR -3.0% (announced $150 mln offering of common stock), APP -2.6% (filed to delay FY14 Form 10-K due to ongoing discussions with Standard General regarding revolving credit facility), ESI -2.5% (filed to delay FY14 Form 10-K), BBX -2.1% (issued statement Regarding BFC Financial Corporation announcement of cash tender offer for shares of BBX Capital Class A Common Stock; Special Committee expects to retain a financial advisor and has retained Hogan Lovells US LLP as its legal advisor), CRR -1.6% (cut quarterly dividend by 70% to $0.10/share from $0.33/share) 

>>> US Close Dow-0,71% S&P-0,33% Nasdaq+0,16% Russell+0,20%

Closing Market Summary: Stocks End Mixed Ahead of FOMC Statement

The stock market ended the Tuesday session on a mixed note ahead of Wednesday's release of the latest policy directive from the Federal Reserve. The Nasdaq Composite added 0.2% while the S&P 500 and Dow Jones Industrial Average lost 0.3% and 0.7%, respectively.

Equity indices endured some selling in the early going, but the Nasdaq spent the day ahead of the broader market thanks to relative strength in the technology sector (+0.1%). Specifically, shares of Apple (AAPL 127.04, +2.09) climbed 1.7%, which underpinned the sector and the Nasdaq. Meanwhile, most large cap components struggled, which was also the case with high-beta chipmakers. The PHLX Semiconductor Index fell 0.7%. That being said, the daylong strength within the technology sector helped the broader market erase the bulk of its early decline.

The Nasdaq received another measure of support from biotechnology with the iShares Nasdaq Biotechnology ETF (IBB 356.25, +2.28) climbing 0.6% to a new record. However, the health care sector (-0.3%) could not turn positive.

Similarly, another influential sector—industrials (-0.4%)—ended in the red even though transport stocks displayed relative strength with the Dow Jones Transportation Average ending just below its flat line. The broader sector could not follow suit as the largest component—General Electric (GE 25.31, -0.14)—lost 0.6%.

Elsewhere among cyclical sectors, energy (-0.5%) settled among the laggards as crude oil faced continued pressure. The energy component fell 1.2% to $43.15/bbl after marking a session low at $42.75/bbl this morning. Crude oil endured a volatile day and made a brief appearance in the green while the Dollar Index (99.66, +0.06) spent the session near its unchanged level. However, the Dollar Index is likely to be active tomorrow when investors respond to the FOMC policy statement.

The main point of focus will be whether the Fed decides to keep its reference to remaining "patient" ahead of the first rate hike. In a recent appearance before the Senate Banking Committee, Fed Chair Janet Yellen said that removing the call for patience would open the door to a potential rate hike at any policy meeting that follows.

Treasuries held solid gains in the morning, but the 10-yr note cut its gain in half, sending the benchmark yield lower by two basis points to 2.06%.

Today's participation was below average with roughly 700 million shares changing hands at the NYSE floor.

Economic data was limited to February housing starts, which declined 17.0% to 897,000 from an upwardly revised 1.081 million (from 1.065 million) while the consensus expected a decline to 1.041 million. Record snowfall in the Northeast and extreme cold in the Midwest likely played a large part in curtailing new construction. Housing starts in these regions declined 45.0% in February, from 262,000 in January to 144,000. Those regions accounted for 64.0% of the entire February decline in housing starts.

Still, the weather can't be completely at fault. Poor underlying economic conditions likely caused some of the February pullback. For example, in the West region, warmer-than-normal temperatures should have helped offset some of the decline from the East, but that did not happen. Starts fell 18.2% to 239,000 in February from 292,000.

Tomorrow, the weekly MBA Mortgage Index will be released at 7:00 ET while the Federal Open Market Committee will release its latest policy statement at 14:00 ET.
  • Nasdaq Composite +4.3% YTD 
  • Russell 2000 +3.2% YTD 
  • S&P 500 +0.7% YTD 
  • Dow Jones Industrial Average +0.2% YTD

>>> Street Views on FOMC ... interesting


FOMC Street Views:

* Barc: Patient removed. See risks are skewed towards the Fed’s revising its growth forecasts lower. Look for potential downward revision to inflation and growth forecasts. They expect lower inflation to likely to weigh on the expected path of the hiking cycle, even as the phrase “patient” is removed. They highlight this was the case between Sept/Dec ’14 as inflation f/cs weakened, despite lower u/e f/cs. In addition, look for Yellen is to emphasize that while the trajectory of the hiking cycle is data dependent, it should be very gradual, given the subdued inflation outlook and sluggish wage growth.

* CS: Expect next week's FOMC to see the "patient" wording removed. They note the dots are the obvious measure that has long been in focus, but the market continues to doubt the dots. Even the dots imply (by their calculations) only two hikes this year. The market remains unwilling to believe that the six hikes in 2016 that the dots currently imply can be realized. They are of the opinion that a few more strong data prints will help to reprice the market’s expectations for Fed action.

* DB: Looks for Fed to alter its forward guidance language to allow the Committee the flexibility to raise interest rates sometime around the middle of this year, possibly in June. This could mean removing "patient" from the meeting statement. Projections should indicate a more confident outlook for the labor market, although this will likely coincide with more tepid near-term inflation forecasts. GS: Fed to recognize the improvement in labour market conditions. Look for Fed to drop patience, replace with language suggesting increase in rates could be warranted if the committee is “reasonably confident” that inflation will move back over the medium term towards 2%. They recognize that a June hike is in play, but not a foregone conclusion. In SEPs; look for growth to be revised lower, inflation will be marked down substantially for 2015 & slightly for 2016, dots to come lower for end-of 2015 to 50-75bp range.

 

* HSBC: Fed drops "patient" reference. Future guidance on possible changes in the federal funds rate is now likely to focus on the state of the economy. They suggest the Committee may look to emphasize that it wants to be "reasonably confident" that inflation will return to 2% before it commences policy normalization. Some of the projections for the appropriate federal funds rate (in the "dot" diagram) might be lowered for 2015, given the reaction to the recent decline in inflation. They expect the Committee to wait until September before taking action.

* JPM: Fed drop "patient" replace it with more data-dependent guidance, stating need "reasonable confidence" in inflation returning to 2% before liftoff. Look for eco f/cs to be projected modestly lower; GDP, inflation, and unemployment, relative to the December f/c. Anticipate the "dots" to be revised somewhat lower as well, particularly for 2015. Yellen's will emphasize; (1) dropping "patient" means June is the earliest lift-off under consideration but that it could come later, and (2) the pace of rate hikes is more consequential than the exact timing of liftoff & it won't necessarily be "measured"—as per the 2004-2006 cycle—but could instead feature pauses between hikes, as conditions dictate.

* MS: Expect “patient” to be dropped. Committee may add that it will look to normalize policy once it feels “reasonably confident” it is appropriate to do so. Committee to remain concerned about international developments given the unrelenting ascent of the US dollar and its implications for growth, inflation, and financial conditions. Expect downward revisions to inflation – both headline and core – as well as the longer-run unemployment. Look for little change to the outlook for growth.

* Soc Gen: Fed to drop the word “patient” in the upcoming FOMC meeting next week but simultaneously lower its near-term forecasts for rates. Their economists expect the Fed to hike rates in June and only one more rate hike by year-end. In terms of market pricing vs. dots, they look for one-third of the gap to be closed by revisions to the FOMC “dots” and the remaining two-thirds by the market. See end of 2015

(BN) Blackstone Is Said Unlikely to Lead Competing Bid for Macerich



Blackstone Is Said Unlikely to Lead Competing Bid for Macerich
2015-03-17 18:16:33.383 GMT


By Hui-yong Yu
(Bloomberg) -- Blackstone Group LP, the world’s largest
private-equity investor in real estate, is unlikely to lead a
takeover offer for Macerich Co., according to a person with
knowledge of the firm’s thinking.
Macerich, the third-biggest publicly traded U.S. mall
owner, earlier Tuesday rejected a $16 billion takeover offer
from Simon Property Group Inc., the largest company in the
industry. REIT Zone, a newsletter, reported last week that
Blackstone may be working with other investors to put together a
group bid for the Santa Monica, California-based real estate
investment trust.
Blackstone hasn’t held talks to organize a competing
proposal and is unlikely to lead a future bid for Macerich, said
the person with knowledge of the matter, who asked not to be
named because the matter is private. The situation remains
fluid, the person said.
Peter Rose, a Blackstone spokesman, declined to comment.
Blackstone had invested with partners in 2010 to bring
General Growth Properties Inc., the No. 2 mall owner, out of
bankruptcy. It sold its shares at a profit three years later.
The New York-based firm also has been expanding in high-quality,
well-leased real estate through a new fund to acquire so-called
core-plus properties.

For Related News and Information:
Macerich Rejects Simon Property’s Bid to Acquire Mall Owner
Blackstone to Buy Chicago’s Willis Tower for $1.3 Billion
Simon’s Pursuit of Macerich Shows Allure of Top-Tier U.S. Malls
Top real estate stories: TOPR <GO>
Merger monitor: MA <GO>

To contact the reporter on this story:
Hui-yong Yu in Seattle at +1-206-262-4146 or
hyu@bloomberg.net
To contact the editors responsible for this story:
Kara Wetzel at +1-415-617-7318 or
kwetzel@bloomberg.net
Christine Maurus